Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,736 filings

Top spenders & firms Spend by issue

Clear
RR
FAEGRE DRINKER BIDDLE & REATH LLP for AMERICAN ACADEMY OF NEUROLOGY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia
Medical/Disease Research/Clinical Labs
View →
Q1
CORNERSTONE GOVERNMENT AFFAIRS, INC. for THE UNIVERSITY OF TEXAS SYSTEM
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $90,000.00 income
Budget/Appropriations, Medical/Disease Research/Clinical Labs, Defense, Science/Technology
View →
RR
BARNES & THORNBURG, LLP for SINAI HEALTH SYSTEM
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q1
CORNERSTONE GOVERNMENT AFFAIRS, INC. for HAZELDEN BETTY FORD FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate · $50,000.00 income
Budget/Appropriations, Defense, Medical/Disease Research/Clinical Labs, Veterans
View →
Q1
SQUIRE PATTON BOGGS for LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · $20,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q1
BLUEBIRD STRATEGIES for NCATS ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medical/Disease Research/Clinical Labs
View →
Q1
BLUEBIRD STRATEGIES for MYOTONIC
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q1
SQUIRE PATTON BOGGS for ALLIANCE FOR BIOSECURITY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q1
AMERICAN COLLEGE OF CLINICAL PHARMACY for AMERICAN COLLEGE OF CLINICAL PHARMACY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Health Issues, Education
View →
Q1
RAY C CULVER III for ARKANSAS CHILDREN'S HOSPITAL
1st Quarter (Jan 1 - Mar 31) 2026 · Arkansas · House · Senate · $10,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q1
DQB INTERNATIONAL for TEXAS BIOMEDICAL RESEARCH INSTITUTE
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate
Medical/Disease Research/Clinical Labs
View →
RR
WINNING STRATEGIES WASHINGTON for SPINAL STABILIZATION TECHNOLOGIES, LTD
1st Quarter (Jan 1 - Mar 31) 2026 · Colorado
Budget/Appropriations, Defense, Health Issues, Medical/Disease Research/Clinical Labs
View →
RR
CORNERSTONE GOVERNMENT AFFAIRS, INC. for RESPOND-US
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia
Defense, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q1
CURE SMA for CURE SMA
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate
Health Issues, Budget/Appropriations, Civil Rights/Civil Liberties, Aviation/Airlines/Airports
View →
Q1
ESHAM STRATEGIES LLC for ACCUMULUS SYNERGY, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · $20,000.00 income
Computer Industry, Science/Technology, Health Issues, Medical/Disease Research/Clinical Labs
View →
4T
THE HARRIS FIRM for HOLISTIC INDUSTRIES INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Small Business, Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs
View →
Q1
MAGILL ASSOCIATES, LLC for THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
RR
AXADVOCACY GOVERNMENT RELATIONS for MAIN LINE HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q1
AUBURN HEALTH STRATEGIES, LLC for AMERICAN PROFICIENCY INSTITUTE
1st Quarter (Jan 1 - Mar 31) 2026 · Michigan
Medical/Disease Research/Clinical Labs
View →
Q1
REPUBLIC CONSULTING, LLC for IQVIA
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues
View →
Q1
MCDERMOTT+ LLC for VERILY LIFE SCIENCES LLC
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $10,000.00 income
Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
NELSON MULLINS RILEY & SCARBOROUGH for ANBEX, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $15,000.00 income
Medical/Disease Research/Clinical Labs, Energy/Nuclear
View →
RR
AKIN GUMP STRAUSS HAUER & FELD for TRANSMEDICS GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts
Medical/Disease Research/Clinical Labs
View →
RR
MILLER STRATEGIES, LLC for ULTRAGENYX PHARMACEUTICAL INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California
Medical/Disease Research/Clinical Labs
View →
RR
THE KPM GROUP DC LLC for MAHZI THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California
Medical/Disease Research/Clinical Labs, Health Issues, Science/Technology
View →
Previous Page 14 of 70 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem